Search Results

Leu-Enkephalin 50 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous opioid peptide; δOR and μOR agonist.

More Information Supplier Page

×

Leu-Enkephalin

Leu-Enkephalin 25 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous opioid peptide; δOR and μOR agonist.

More Information Supplier Page

×

Leu-Enkephalin

Endothelin-3, human 2.5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous peptide, involved in vascular contraction. ET-B agonist.

More Information Supplier Page

×

Endothelin-3, human

Endothelin-3, human 1 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous peptide, involved in vascular contraction. ET-B agonist.

More Information Supplier Page

×

Endothelin-3, human

Epoxiconazole 10 g  | ≥95%

LKT Laboratories, Inc.

Triazole; 14-α demethylase inhibitor, potential aromatase inhibitor.

More Information Supplier Page

×

Epoxiconazole

Epoxiconazole 100 g  | ≥95%

LKT Laboratories, Inc.

Triazole; 14-α demethylase inhibitor, potential aromatase inhibitor.

More Information Supplier Page

×

Epoxiconazole

Exendin-3 2.5 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, GLP-1 analog found in Heloderma; GLP-1 agonist.

More Information Supplier Page

×

Exendin-3

Exendin-3 1 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, GLP-1 analog found in Heloderma; GLP-1 agonist.

More Information Supplier Page

×

Exendin-3

Exendin-3 0.5 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, GLP-1 analog found in Heloderma; GLP-1 agonist.

More Information Supplier Page

×

Exendin-3

Estramustine Phosphate Disodium 1 g  | ≥95%

LKT Laboratories, Inc.

Nitrogen mustard and estradiol derivative; microtubule depolymerization inducer.

More Information Supplier Page

×

Estramustine Phosphate Disodium